Joseph Mazar, PhD (he/him/his)

Research Scientist/Assistant Professor
Nemours Children's Health
Davenport, Florida, United States

Presentation(s):

• The Oncolytic Activity of Zika Viral Therapy Confers a Dramatic Survival Advantage in High-Risk Neuroblastoma In Vivo Models

  Saturday, May 4, 2024
  11:30 AM – 11:45 AM ET

  Disclosure(s): I do not have any relevant financial / non-financial relationships with any proprietary interests.